Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-04-11 5:00 pm Purchase |
2025-04-10 | 13D | Mangoceuticals, Inc. MGRX |
Jacob D. Cohen | 921,666 11.000% |
921,666 (New Position) |
Filing History |
| 2025-01-22 5:28 pm Purchase |
2024-12-13 | 13G | Mangoceuticals, Inc. MGRX |
Greenfield Investments, Ltd | 515,000 14.440% |
515,000 (New Position) |
Filing History |
| 2024-08-27 7:45 pm Purchase |
2024-08-26 | 13D | Mangoceuticals, Inc. MGRX |
Jacob D. Cohen | 721,667 34.200% |
16,667 (+2.36%) |
Filing History |
| 2024-06-05 5:15 pm Purchase |
2024-06-03 | 13D | Mangoceuticals, Inc. MGRX |
Jacob D. Cohen | 705,000 34.700% |
53,333 (+8.18%) |
Filing History |
| 2023-12-29 9:51 pm Purchase |
2023-12-28 | 13D | Mangoceuticals, Inc. MGRX |
Jacob D. Cohen | 651,667 42.600% |
100,000 (+18.13%) |
Filing History |
| 2023-05-02 8:55 pm Purchase |
2023-04-10 | 13D | Mangoceuticals, Inc. MGRX |
Jacob D. Cohen | 551,667 47.800% |
551,667 (New Position) |
Filing History |